TELA Bio, Inc.
TELA· Nasdaq
TELATELA Bio, Inc.
Filed May 15, 2020 · 10-Q · 45 days after period end · 0001558370-20-006726
| Metric | Q1 2020 | Q1 2019 |
|---|---|---|
| Revenue | $3.73M | $3.31M |
| Net Income | -$7.22M | -$5.97M |
| EPS Diluted | -$0.63 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
TELA Bio, Inc. · CIK 1561921 · Engraved from SEC EDGAR
ended Mar 31, 2020 · filed May 15, 2020 · 45 d after period end
